Best practices to fund, develop and commercialize evidence-based mental health innovation

In this ses­sion we dis­cuss key lessons learned for sci­en­tists and start-ups to suc­cess­ful­ly bring to mar­ket evi­dence-based inno­v­a­tive solu­tions. We will present non-dilu­tive fund­ing oppor­tu­ni­ties and com­mer­cial­iza­tion resources offered through the US small busi­ness research pro­grams, and a sci­en­tist and inven­tor turned ser­i­al entre­pre­neur wrap-ups the day shar­ing insights from his pre­vi­ous venture–funded by the NIMH and sold to McKesson–and his cur­rent strat­e­gy and vision.

• Chair: Dr. Ali­son Fen­ney, Exec­u­tive Direc­tor of the Neu­rotech­nol­o­gy Indus­try Organization
• Dr. Mar­garet Grabb, SBIR/STTR Pro­gram Direc­tor at the Nation­al Insti­tute of Men­tal Health (NIMH)
• Dr. Rex Jakobovits, Founder of Viva­l­og Tech­nolo­gies and Experiad

These pre­sen­ta­tions took place at the 2016 Sharp­Brains Vir­tu­al Sum­mit: Rein­vent­ing Brain Health in the Dig­i­tal Age (Decem­ber 6–8th, 2016).